ReviewClinical chemistry2011
Prediabetes as a therapeutic target.
Review in Clinical chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 52 citations in OpenAlex.
- Acceptability of predictive testing for ischemic heart disease in those with a family history and the impact of results on behavioural intention and behaviour change: a systematic review.BMC public health · 2022Pooled it
- Comparison of control fasting plasma glucose of exercise-only versus exercise-diet among a pre-diabetic population: a meta-analysis.European journal of clinical nutrition · 2016Pooled it
- Prevalence of Non-diabetic Hyperglycemia in Young Adults and Its Impact on Periodontal Health.Cureus · 2024Article
- Association between sarcopenia and prediabetes among non-elderly US adults.Journal of endocrinological investigation · 2023Article
- Article
- Palmatine ameliorates high fat diet induced impaired glucose tolerance.Biological research · 2020Article
- Uric acid and diabetes risk among Chinese women with a history of gestational diabetes mellitus.Diabetes research and clinical practice · 2017Article
- All-Cause Mortality Risk in Australian Women with Impaired Fasting Glucose and Diabetes.Journal of diabetes research · 2017Article
- Plasma lipid levels predict dysglycemia in a biracial cohort of nondiabetic subjects: Potential mechanisms.Experimental biology and medicine (Maywood, N.J.) · 2016Article
- Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications.Experimental biology and medicine (Maywood, N.J.) · 2016 · on this mapReview
- Rational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markers.SpringerPlus · 2015Article
- Dysglycaemia and Other Predictors for Progression or Regression from Impaired Fasting Glucose to Diabetes or Normoglycaemia.Journal of diabetes research · 2015Article
- Has the Required Importance Been given to the Diagnosis and Treatment of Prediabetes?International journal of preventive medicine · 2014Article
- Serum uric acid level and its association with cardiometabolic risk factors in prediabetic subjects.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2014Article
- Evaluation of current eligibility criteria for bariatric surgery: diabetes prevention and risk factor changes in the Swedish obese subjects (SOS) study.Diabetes care · 2013Article
- Association of serum uric acid with 2-hour postload glucose in Chinese with impaired fasting plasma glucose and/or HbA1c.PloS one · 2013Article
- A rodent model of rapid-onset diabetes induced by glucocorticoids and high-fat feeding.Disease models & mechanisms · 2012Article
- Genetic modifications of pigs for medicine and agriculture.Molecular reproduction and developmentReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
backgroundThe term "prediabetes" is used to describe a condition that involves impaired glucose tolerance (IGT) or impaired fasting glucose (IFG). IGT is defined by a 2-h oral glucose tolerance test plasma glucose concentration >140 mg/dL (7.8 mmol/L) but <200 mg/dL (11.1 mmol/L), and IFG is defined by a fasting plasma glucose concentration ≥100 mg/dL (5.6 mmol/L), but <126 mg/dL (7.0 mmol/L). Studies have shown that people with prediabetes tend to develop type 2 diabetes within 10 years and are at increased risk for cardiovascular disease and death even before the development of diabetes. CONTENT: In this minireview we discusses the epidemiology, pathophysiology, and clinical implications of prediabetes. The rationale for therapeutic intervention in people with prediabetes, the goals of intervention, and the specific tools for intervention are presented. Emphasis is placed on data from randomized controlled clinical trials, whenever such data are available. SUMMARY: Approximately 57 million Americans have prediabetes and are consequently at risk for cardiometabolic complications. Lifestyle modifications (dietary restriction and exercise) and certain medications can prevent the development of diabetes in persons with prediabetes. Lifestyle intervention also has been demonstrated to decrease cardiovascular disease risk markers, although data on clinical events are lacking.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.